| 2009 April |
Promising interim results from Hybrigenics’ Inecalcitol Phase II in Combination with Taxotere® for Hormone-Refractory Prostate CancerParis, April, 17th 2009 - Hybrigenics will present interim results at the 2009 Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida on May 31 |